Metastasectomy for stage IV melanoma

Surgical Oncology Clinics of North America
Gary B DeutschMark B Faries

Abstract

Metastatic melanoma has an unpredictable natural history but a predictably high mortality. Despite recent advances in systemic therapy, many patients do not respond, or develop resistance to drug therapy. Surgery has consistently shown good outcomes in appropriately selected patients. It is likely to be even more successful in the era of more effective medical treatment. Surgery should remain a strongly considered option for metastatic melanoma.

References

Aug 1, 1986·Annals of Surgery·I L WornomC M Balch
Sep 1, 1996·Archives of Surgery·D W OllilaD L Morton
Jan 9, 1999·Journal of Surgical Oncology·D W OllilaD L Morton
Nov 7, 2000·Cancer·T MeyerW Hohenberger
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Omar EtonRobert S Benjamin
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Oct 24, 2002·Current Treatment Options in Oncology·Eddie K Abdalla, Peter W T Pisters
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eddy C HsuehDonald L Morton
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K M FifeJ F Thompson
Sep 24, 2004·Archives of Surgery·Richard EssnerDonald L Morton
Mar 9, 2006·Annals of Surgical Oncology·Alice C WeiSteven Gallinger
Mar 28, 2006·Seminars in Radiation Oncology·James C YangRichard Sherry
Apr 25, 2006·Surgical Oncology Clinics of North America·Steven O'Day, Peter Boasberg
Nov 4, 2006·The Lancet Oncology·David W Ollila
Jan 3, 2007·The Journal of Thoracic and Cardiovascular Surgery·Rebecca P PetersenDavid H Harpole
Aug 8, 2007·Annals of Surgical Oncology·Heather B NeumanDaniel G Coit
Jan 22, 2008·American Journal of Surgery·Elizabeth A MittendorfJeffrey E Lee
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward L KornJohn M Kirkwood
Jun 17, 2008·Cancer Treatment Reviews·Steve R Martinez, Shawn E Young
Mar 6, 2009·The Lancet Oncology·Sushanth Reddy, Christopher L Wolfgang
Mar 31, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P MarianiR J Salmon
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven J O'DayJeffrey S Weber
Jan 6, 2010·Japanese Journal of Clinical Oncology·Yuzuru Niibe, Kazushige Hayakawa
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Dec 15, 2010·American Journal of Clinical Oncology·Agop Y BedikianPatrick Hwu
Jan 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoine BrouquetJean-Nicolas Vauthey
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 23, 2011·Nature Reviews. Clinical Oncology·Ralph R Weichselbaum, Samuel Hellman
Apr 12, 2011·Journal of Neurosurgery·Russell R LonserSteven A Rosenberg
May 25, 2011·Nature Reviews. Clinical Oncology·Simon S LoRobert D Timmerman
Aug 23, 2011·Journal of Surgical Oncology·David W OllilaEddy C Hsueh
Sep 14, 2011·Journal of Gastrointestinal Cancer·Jatinder GoyalEmmanuel S Antonarakis
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Dec 13, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grant R KolarGerald P Linette
Dec 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin B KimKarl D Lewis
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
May 15, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J D WolchokC Lebbé

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Surgical Oncology Clinics of North America
Abigail S Caudle, Merrick I Ross
Ostomy/wound Management
Lia van Rijswijk
Expert Review of Anticancer Therapy
Eleni JosephidesAneta Suder
© 2021 Meta ULC. All rights reserved